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Abstract
Background: We examined the effects of the R325W mutation on the three-dimensional (3D) structure of the β-cell-
specific Zn2+ (zinc) transporter ZnT-8.
Methods: A model of the C-terminal domain of the human ZnT-8 protein was generated by homology modeling 
based on the known crystal structure of the Escherichia coli (E. coli) zinc transporter YiiP at 3.8 Å resolution.
Results: The homodimer ZnT-8 protein structure exists as a Y-shaped architecture with Arg325 located at the ultimate 
bottom of this motif at approximately 13.5 Å from the transmembrane domain juncture. The C-terminal domain 
sequences of the human ZnT-8 protein and the E. coli zinc transporter YiiP share 12.3% identical and 39.5% 
homologous residues resulting in an overall homology of 51.8%. Validation statistics of the homology model showed a 
reasonable quality of the model. The C-terminal domain exhibited an αββαβ fold with Arg325 as the penultimate N-
terminal residue of the α2-helix. The side chains of both Arg325 and Trp325 point away from the interface with the 
other monomer, whereas the ε-NH3
+ group of Arg325 is predicted to form an ionic interaction with the β-COO- group 
of Asp326 as well as Asp295. An amino acid alignment of the β2-α2 C-terminal loop domain revealed a variety of 
neutral amino acids at position 325 of different ZnT-8 proteins.
Conclusions: Our validated homology models predict that both Arg325 and Trp325, amino acids with a helix-forming 
behavior, and penultimate N-terminal residues in the α2-helix of the C-terminal domain, are shielded by the planar 
surface of the three cytoplasmic β-strands and hence unable to affect the sensing capacity of the C-terminal domain. 
Moreover, the amino acid residue at position 325 is too far removed from the docking and transporter parts of ZnT-8 to 
affect their local protein conformations. These data indicate that the inherited R325W abnormality in SLC30A8 may be 
tolerated and results in adequate zinc transfer to the correct sites in the pancreatic islet cells and are consistent with 
the observation that the SLC30A8 gene variant R325W has a low predicted value for future type 2 diabetes at 
population-based level.
Background
This report continues our analyses of the genetic factors
playing an important role in the pathogenesis of type 2
diabetes [1]. Genome-wide association studies have cur-
rently identified single nucleotide polymorphisms (SNPs)
within up to 10 genes associated with an increased risk of
type 2 diabetes [2-6]. Several of the SNPs identified
within or near these genes are hypothesized to influence
β-cell function. Previous studies of the latter genes addi-
tionally identified the SNP rs13266634 as a nonsynony-
mous SNP causing an arginine to tryptophan change at
position 325 (R325W) in the last exon of the solute car-
rier family 30 (zinc transporter; ZnT) member 8
(SLC30A8) gene on 8q24 (Table 1). Yet, contrary to the
outcomes of the above-mentioned association studies,
combining the genetic variants including the SLC30A8
gene variant R325W was recently reported to have low
predicted value for future type 2 diabetes at population-
based level [7-10]. From a different point of view, we con-
tinued our analyses to have informed discussion, and
studied at atomic level the impact of the R325W muta-
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tion on ZnT-8 complete with sensor, actuator and trans-
porter parts.
The SLC30A8 gene encodes a 369-amino acid protein,
ZnT-8, that transports Zn2+ (zinc) from the cytoplasm
into insulin secretory vesicles, where insulin is stored as a
hexamer bound with two zinc ions before secretion [11-
14]. The ZnT-8 protein is specifically expressed in pan-
creatic β-cells and thus may be of primary importance for
the insulin secretory pathway. Variations in SLC30A8
may affect zinc accumulation in insulin granules, affect-
ing insulin stability, storage, or secretion.
In mammalian cells, eight homologous zinc export pro-
teins, named ZnT-1 to -8, have been described [11,14].
These proteins are members of the SLC30 subfamily of
the cation diffusion facilitator family. Analysis of genome
sequences shows that cation diffusion facilitators repre-
sent a ubiquitous protein family, encompassing more
than 400 evolutionarily related members found in species
ranging from bacteria and yeast to plants and mammals
[15-17]. This protein family is characterized by an N-ter-
minal hydrophobic domain in addition to a C-terminal
cytosolic, hydrophilic region that is highly variable both
i n  s e q u e n c e  a n d  i n  l e n g t h  [ 1 8 ]  w i t h  a  c o m m o n  a n d
remarkably evolutionarily conserved αββαβ fold. Despite
the relatively low sequence homology in the cytoplasmic
domains, the structural homology between them is
impressive. For example, the αββα structural core of the
C-terminal domain from α1 to α2 of the E. coli zinc trans-
porter YiiP can be superimposed onto the equivalent por-
tion of human copper metallochaperone Hah1 with a
root mean square deviation of 1.8 Å for 42 common Cα
positions, although there is no sequence homology
between the C-terminal domain and Hah1 after a evolu-
tionary period of more than thousand millions of years
[[19], see ref. [21]], while the soluble fragment from Ther-
mus thermophilus zinc transporter CzrB overlays the
cytoplasmic domain of YiiP with a Cα-root mean square
deviation of 1.8 Å over 79 residues with an overall
sequence identity of 8.8% [20].
The zinc transporting function is attributed to the
homologous hydrophobic domain, which is thought to be
composed of a bundle of six transmembrane segments,
denoted as TM1 to TM6, in an α-helical configuration, a
structural theme found in many other membrane chan-
nels and transporters [21,22]. A representative member
of the cation diffusion facilitator family is YiiP, a dimer of
two identical 33-kD integral zinc transporter membrane
proteins found in the plasma membrane of E. coli [23].
Recently, X-ray diffraction analysis of YiiP crystals and 12
heavy-atom derivative crystals revealed YiiP dimers at a
resolution of 3.8 Å with individual subunits, each con-
taining six bilayer-spanning α-helices, a C-terminal
domain with an αββαβ fold, and four zinc-populated sites
(Fig. 1) [19,24]. Most recently, the C-terminal domain of
CzrB was overexpressed in E. coli and the crystal struc-
ture of the apo and zinc forms of the soluble fragment
(CzrBsf) solved to 1.7 and 1.8 Å, respectively [20]. We
have used this, in combination with the structure of YiiP,
to examine the effects of the missense mutation on the
3D structure of the ZnT-8 protein complete with sensor,
actuator and transporter parts.
Methods
We retrieved information regarding the amino acid
sequences of human ZnT-2 (Q9BRI3), ZnT-3 (Q99726),
and ZnT-8 (Q8IWU4), mouse ZnT-8 (Q8BGG0), E. coli
zinc transporters YiiP (Q1R404) and ZitB (Q8×400),
Thermus thermophilus zinc transporter CzrB (Q8vlX7)
and  Ralstonia metallidurans zinc transporter CzcD
(P13512) from the UniProtKB/Swiss-Prot databank [25].
The crystal structure of YiiP was retrieved from the Pro-
tein Data Bank [19,26]. C-terminal domains of Homo
Table 1: Overview of confirmed type 2 diabetes association results in the combined stage 1 and 2 samples for the widely 
replicated type 2 diabetes-associated variant SLC30A8 R325W (rs13266634).
Study Total sample size; stage 1+2 
(number of cases/controls)
OR (95% CI) P-value Ref.
DGI 13,781 (6,529/7,252) 1.07 (1.00-1.16) 0.047 2
WTCCC/UKT2D 13,965 (5,681/8,284) 1.12 (1.05-1.18) 7.0 × 10-5 3
FUSION 4,808 (2,376/2,432) 1.18 (1.09-1.29) 7.0 × 10-5 4
DGI-WTCCC/UKT2D- FUSION (all 
data)
32,554 (14,586/17,968) 1.12 (1.07-1.16) 5.3 × 10-8 2-4
Icelandic case control* 16,398 (3,836/12,562) 1.15 (1.08-1.22) 3.3 × 10-6 5
France case control 5,511 (2,617/2,894) 1.18 (0.93-1.43)† 1.53 (1.22-1.84)‡ 6.1 × 10-9 6
*Combined European ancestry groups. †Heterozygous. ‡Homozygous.Weijers Diabetology & Metabolic Syndrome 2010, 2:33
http://www.dmsjournal.com/content/2/1/33
Page 3 of 8
sapiens ZnT-8 and E. coli zinc transporter YiiP sequences
were aligned and with a typical homology modeling exer-
cise, the most probable 3D models were created with the
program Modeller, version 9 [27]. The model was vali-
dated using the PSVS validation server [28-31] exclusive
of the MolProbity clashscore because for this sort of anal-
ysis to be reliable, the reference crystal structure needs to
be better than 2.0 Å resolution [32] (Table 2). All model
representations were prepared using the program Pymol
(DeLano Scientific) [33]. Secondary structure elements of
the C-terminal domain of the zinc transporters CzrB
were indicated as α-helices and β-pleated sheets accord-
ing to the specifications of Cherezov et al. [20].
Results
We focused our analyses on the C-terminal domain of
ZnT-8 because position 325, at which the mutation takes
place, is located on this part of the protein. A model of
the C-terminal domain of the human ZnT-8 protein was
generated by homology modeling based on the known
crystal structure of the E. coli zinc transporter YiiP at 3.8
Å resolution. The two sequences share 12.3% identical
and 39.5% homologous residues (Fig. 2) resulting in an
overall homology of 51.8%, which is well within the safe
limits for homology modeling. A model was generated
with Modeller [27] and validated using the PSVP valida-
tion server (Table 2) [28]. The generated models of the
wild-type ZnT-8 protein and its Arg325Trp variant
revealed a Y-shaped architecture consisting of a pair of
identical protein chains, each composed of six transmem-
brane domains, a hydrophilic C-terminal domain with a
αββαβ fold and four zinc receiving domains (designated
as Z1 to Z4) (figure not shown). In our model, the Arg325
side-chain is at approximately 15 Å from the Z2 site.
Fig. 3 displays the superposition of the loop connecting
the second β-strand to the second α-helix of the C-termi-
nal domain of the ZnT-8 R325W variant upon the struc-
ture of the YiiP zinc transporter. The α2-helix of the ZnT-8
mutated protein has Trp325 as the penultimate N-terminal
residue. Further, the side-chain of Trp325 points away
from the interface with the other monomer. In the wild-
type ZnT-8 protein, the α2-helix has Arg325 as the penulti-
mate N-terminal residue, while the Arg325 side-chain has
an orientation virtually identical to that of Trp325 in the
ZnT-8 R325W variant (Fig. 4). Arg325 may form an inter-
chain noncovalent, electrostatic interaction (salt bridge)
with its adjacent Asp326 and an intrachain salt bridge with
Asp295 of the α1-helix of the C-terminal domain (Fig. 4).
Table 3 shows the alignment of loop-domains linking the
second β-strand to the second α-helix of the C-terminal
domain of ZnT-8 and other ZnT proteins. The secondary
structure elements (α-helix, β-strand, and loop) are indi-
cated according to the 1.8 À resolution zinc-CzrBsf model
[20]. Position 325, at which the mutation takes place, cor-
responds to a charged Arg residue. By replacing it with a
Trp residue, the positive charge is removed, thereby
affecting the electrostatic interactions with the protein.
Figure 1 Biological molecule image for the zinc transporter YiiP 
(17). The biological molecule consists of a pair of identical protein 
chains, each composed of (a) six transmembrane domains (blue and 
green) at the extracellular side, (b) a hydrophilic C-terminal domain 
with a αββαβ fold (red and orange) at the intracellular side, and (c) four 
zinc-populated sites (top-down designated as Z1 to Z4). Zinc ions are 
represented by gray spheres.
Table 2: Validation statistics of the homology model of the 
C-terminal domain of YiiP generated with the PSVS server .
Structure quality factors - overall statistics
Mean score Z-scorea
Procheck G-factor (phi/psi only) [29] - 0.75 - 2.64
Procheck G-factor (all dihedral angles) 
[29]
- 0.49 - 2.90
Verify3D [30] 0.22 - 3.85
ProsaII (-ve) [31] 0.09 - 2.32
Ramachandran plot summary from Procheck [29]
Most favoured regions 72.0%
Additionally allowed regions 17.3%
Generously allowed regions 8.0%
Disallowed regions 2.7%
aWith respect to mean and standard deviation for a set of 252 X-
ray structures < 500 residues, of resolution ≤ 1.80 Å, R-factor ≤ 
0.25 and R-free ≤ 0.28; a positive value indicates a 'better' score.Weijers Diabetology & Metabolic Syndrome 2010, 2:33
http://www.dmsjournal.com/content/2/1/33
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Discussion
This report is a description of a 3D atomic-resolution
model of the C-terminal domain of a β-cell-specific Zn2+
transporter, ZnT-8, predicted from the type 2 diabetes-
associated gene variant SLC30A8 R325W. As for studies
in zinc transporter functioning [20,34], we used homol-
ogy modeling, which is based on the general observation
that evolutionarily related (homologous) proteins are
likely to have similar structures and currently gives the
most accurate and reliable models [35]. We built struc-
tural models for ZnT-8 and its gene variant R325W, based
on the known structure of a close homologue (template)
YiiP, a membrane transporter that catalyzes Zn2+/H+
exchange across the inner membrane of E. coli. The qual-
Figure 2 Alignment of the human ZnT-8 (lower row) and E. coli zinc transporter YiiP (upper row) C-terminal domain sequences. Amino acid 
residues are indicated by single letters. A vertical line connects identical residues and a * connects homologous residues.
223 ALPDE-ERQEIIDIVTSWPGVSGAHDLRTR-QSGPTRFIQIHLEMEDSLPLVQAHMVADQ
**
277 GVPKSLNYSGVKELILAVDGVLSVHSLHIWSLTMNQVILSAHV-ATAA--SRDSQVVRRE
234 VEQAILRRFPGSDVIIHQDPCSVV
* 
303 IAKALSKSFTMHSLTIQMESPVDQ
Figure 3 In this diagram of the ZnT-8 R325W variant, the loop domain linking β2 to α2 at the outer edge of the C-terminal domain intrac-
ellular part faces the viewer. Note that Trp325 points away from the interface with the other monomer. The bacterial structure is indicated in green, 
the human structure in yellow, and the other monomer in blue. The four front spheres at the interface of the intracellular domains represent the po-
sitioning of the two binuclear zinc ion clusters in sites Z3 and Z4 in each of the protomers, and the faint back spheres the zinc ion in site Z2 in each of 
the protomers. The side-chains of Trp325, Asp326, and Asp295 are presented by a "ribbon structure".Weijers Diabetology & Metabolic Syndrome 2010, 2:33
http://www.dmsjournal.com/content/2/1/33
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Figure 4 Close-up view of the loop domain linking β2 to α2 (in front of the figure) at the outer edge of the C-terminal domain intracellular 
part of the 3D structure of the wild-type ZnT-8 protein. Note that Arg325 points away from the interface with the other monomer. The bacterial 
structure is indicated in green, the human structure in yellow, and the other monomer in blue. The four front spheres at the interface of the intracel-
lular domains represent the positioning of the two binuclear zinc ion clusters in sites Z3 and Z4 in each of the protomers, and the back spheres the 
zinc ion in site Z2 in each of the protomers. At the back of the figure, the faint sphere represents a zinc ion in site Z1. The model predicts salt bridges 
linking the ε-NH3
+ group of Arg325 and the β-COO- group of Asp326 as well as Asp295. The side-chains of Arg325, Asp326, and Asp295 are presented 
by a "ribbon structure".
Table 3: Sequence alignment of the loop domain linking β2 to α2 of YiiP and representative members of the cation 
diffusion facilitator family.
CDF homologs Amino acid sequence Residue number
*----β2---Ј *-L3-Ј *----- α2 --------
YiiP PTRFIQIHLE MEDSLP LVQAHMVADQVEQAI 286
CzrB PRSFLEFHLV VRGDTP VEEAHRLCDELERAL 269
ZitB EKPVMTLHVQ VI---P PHDHDALLDQIQHYL 275
CzcD GKASLTVHVV NDTA-- VNPEMEVLPELKQML 273
msZnT-8 NQVILSVHVA TA---A SQDSQSVRTGIAQAL 337
hmZnT-2 AQPVLSVHIA IAQN-- -TDAQAVLKTASSRL 293
hmZnT-3 TYHVASAHLA IDST-- -ADPEAVLAEASSRL 357
hmZnT-8 NQVILSAHVA TA---A SRDSQVVRREIAKAL 339
The human ZnT-8 residue R325 is in boldface. YiiP and ZitB are bacterial CDF homologs from Escherichia coli, CzcD from Ralstonia 
metallidurans, CzrB from Thermus thermophilus, msZnT-8 from Mus musculus (mouse), and ZnT-2, ZnT-3, and ZnT-8 from Homo Sapiens.Weijers Diabetology & Metabolic Syndrome 2010, 2:33
http://www.dmsjournal.com/content/2/1/33
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ity of the homology model is dependent of the quality of
the sequence alignment and template structure [36].
Alignment of the ZnT-8 and YiiP C-terminal domain
sequences revealed an overall homology of 51.8%, which
is well within the safe limits for homology modeling (Fig.
2). The model had 89.3% residues in the allowed regions
of the Ramachandran plot, a value consistent with a value
of 90.1% reported for the total structure of ZnT-8 [37].
The YiiP protein shows the main characteristics of a
family of ubiquitous zinc transporters termed cation dif-
fusion facilitator including: (a) a homodimer held
together in a parallel orientation through four zinc ions at
the interface of the cytoplasmic domains, with the two
transmembrane domains swung out to yield a Y-shaped
structure; (b) a 33-kD integral transmembrane protein
composed of a compact bundle of six transmembrane
segments in an α-helical configuration (residues 1-211)
arranged in a way that creates an extra- and an intracellu-
lar cavity on either side of the membrane to make room
for one zinc ion, Z1 and Z2, respectively; and, finally, (c) a
hydrophilic C-terminal domain (residues 212-300) con-
sisting of three β-strands and two α-helices (α1-β1-β2-
α2-β3 order). The latter exists as a three-stranded anti-
parallel β-sheet with the overall shape of a flattened ellip-
soid. The rounded part of the domain is made up of the
two α-helices laying on top of the β-sheets [38-40]. At the
interface with the other monomer and close to the β-
sheets, a binuclear zinc cluster is located at the sites Z3
and Z4 (Figs. 3 and 4). Finally, the ZnT-8 protein was pre-
dicted to adopt the same topology as the other ZnT pro-
teins with six transmembrane helices [11]. Collectively,
the data presented here suggest that the quality of the
sequence alignment and template structure tend to be
reliable for producing a 3D model of the ZnT-8 C-termi-
nal domain to investigate the structural consequences of
the substitution of Trp for Arg at position 325.
Recently, Cherezov et al. reported seminal data on the
mechanism of transmembrane zinc transport via the
putative zinc transporter CzrB [20]. Briefly, the proposed
transport model suggests that in the absence of zinc the
two flattened ellipsoids (αββαβ motif) as a dimer are
splayed apart by charge repulsion. This will contribute to
holding the two C-terminal domains apart and will serve
to direct zinc ions into Z3 and Z4 as the intracellular con-
centrations of the ion rise. Thus, the cytosolic zinc con-
centration is sensed by the exposed C-terminal domain.
When zinc binds to Z3 and Z4, a large conformational
c h a n g e  o c c u r s  t h a t  c l o s e s  t h e  t w o  e l l i p s o i d s  ( α β β α β
motif) and hence enlarge the dimerization surface area
from ~400Å in the absence of zinc to ~1050Å in its pres-
ence. The net effect of this zinc binding is to change the
relative disposition of the cytosolic Z2 domain environ-
ment in such a way that a zinc-loaded metallochaperone
can dock for delivery and transport of its zinc cargo to
this intracellular cavity. The ion then travelers across the
membrane into the extracellular cavity Z1 where effec-
tively it is out of the cell.
Our homology model predicts that the Arg325 side-
chain is located at approximately 15 Å from the compact
bundle of six transmembrane helices. It is thus rather dis-
tant from the transmembrane domain site including the
extra- and the intracellular cavity Z1 and Z2, respectively,
which suggests that the Arg to Trp substitution at posi-
tion 325 is unlikely to affect the protein folding near the
cavity loci and the uploading of zinc.
The overall shape of the C-terminal domain is that of
an flattened ellipsoid existing of three β-strands with the
central strand running parallel and anti-parallel to its
neighbor on either side and on top two α-helices. The
three β-sheets create a planar and distinctly polar surface
of the ellipsoid with a pronounced negative charge at the
interface with the other monomer, the region with the
bridged zinc ions Z3 and Z4 [20]. Our models predict
that both the side chain of Arg325 and Trp325 point away
from the interface with the other monomer (Fig. 3, 4).
These data suggest that the amino acid residue at position
325 is neither involved in dimerization contacts, nor in
the zinc coordination sites Z3 and Z4, and that the three
β-sheets shield the positive charge of the ε-NH3
+ group of
Arg325 from the sites Z3 and Z4 [[19], see Fig. S3; [20],
see Fig. 3]. The existence of an positively charged Arg325
side chain on the outside of the ellipsoid pointing away
from the interface with the other monomer in the pres-
ence a pronounced negative charge on the inner side of
the ellipsoid reflects this effective way of shielding. The
above data support the concept that the substitution of
Trp for Arg at position 325 is unlikely to affect the protein
folding of the exposed C-terminal domain, the sensor of
the cytosolic zinc concentration.
Furthermore, our model of the wild-type ZnT-8 pre-
dicts an inter- and an intrachain salt bridge linking the ε-
NH3
+ group of Arg325 to both the β-COO- group of
Asp326 and Asp295. Because the magnitude of the elec-
trostatic force between two point electric charges is
inversely proportional to the square of the total distance
between the two charges, the magnitude of the electro-
static force between Arg325 and Asp295 is approximately
25% compared to the magnitude of the electrostatic force
between Arg325 and Asp326. These observations suggest
that the electrostatic interactions marginally contribute
to the stabilization of the αββαβ fold of the C-terminal
domain. A Trp325 would fit there, but the salt bridges
would be lost, and this loss could alter the conformational
state of the α1-helix and, in turn, the zinc binding and
transport. Surprisingly, sequence alignment of wild-type
ZnT-8 and YiiP revealed that Arg325 found in the former
protein seems to be replaced by a Val residue in the latterWeijers Diabetology & Metabolic Syndrome 2010, 2:33
http://www.dmsjournal.com/content/2/1/33
Page 7 of 8
protein, implying the disappearance of the salt bridges in
the protein structure of YiiP (Table 2). For similar rea-
sons, these salt bridges are absent in the prototypes of the
bacterial members of the cation diffusion facilitator fam-
ily homologs CzrB from Thermus thermophilus, ZitB
from E.Coli and CzcD from Ralstonia metallidurans, and
in mouse ZnT-8 (Table 2). A sequence alignment of the
C-terminal domain from the ZnT-2, -3, and -8 proteins
revealed that Arg325 in ZnT-8 was substituted by Thr279
in ZnT-2 and by Ala343 in ZnT-3 (Table 2). Additionally,
an analysis of the phylogenetic tree for all identified
human ZnT family proteins indicated that ZnT-2, -3, and
-8 cluster closely together [19]. Thus, independent of the
existence of the inter- and intrachain salt bridges, all cur-
rently known structures of metallochaperones and their
target domains fully control the activity of intracellular
zinc transport [39].
In contrast to our study on ZnT-8, Nicolson et al.
reported that cells expressing the ZnT-8 Trp325 protein
transport more zinc into cells, than cells expressing wild-
type ZnT-8 Arg325 protein [37]. However, these observa-
tions are likely incorrect, because these conclusions
appear to be based on an assay for ZnT-8 transporter
activity revealing that the transporter may operate in the
reverse direction whereas there are no ATPase domains
in ZnT-8 which may be required for ZnT-8 to operate in
the reverse direction. For instance, non-specific events
may be responsible for the observed different rates of zinc
transport, i.e., difference in the number of zinc transport-
ers per area unit of secretory granules of β-cells express-
ing either wild-type or Trp325 variant of ZnT-8, or
difference in background color of microscopy images of
control cells versus β-cells expressing either wild-type or
Trp325 variant of ZnT-8, as very similar experiments
revealed a substantial amount of zinc in control cells in
normal conditions versus ZnT-8-expressing cells, i.e., 830
± 109 μg Zn/g protein and 1072 ± 78 μg Zn/g protein,
respectively [12]. Nicolson et al. also concluded that the
resultant introduction of positive charge into the region
of monomer interface of ZnT-8, close to the predicted
sites of bound structurally important zinc ions, may be
expected to affect the kinetics of zinc transport [37].
Without any particular detail of a 3D model for ZnT-8,
their conclusions are based merely on the observation
that R325 resides at the monomer interface as our models
predict that the side chains of both Arg325 and Trp325
point away from the interface with the other monomer.
To resolve the above discussed differences and to show
that wild-type Arg325 and Trp325 variant of ZnT-8 are
no different in their ability to form dimers and their abil-
ity to transport zinc, we propose to improve the experi-
mental conditions to prevent reverse zinc transport as
described for ZnT-8 [37] and ZnT-5 [41]. Next, we pro-
pose the following sequence of experiments: (a) to assay
directly the functional activity of ZnT-8, measure the
transmembrane flux of zinc across the plasma membrane
of Xenopus laevis oocytes [41]; (b) inject oocytes with
wild-type Arg325 ZnT-8 RNA, with Trp325 variant of
ZnT-8 RNA or water; (c) assay zinc uptake into oocytes
by measuring 65Zn2+ incorporation into single oocytes as
γ emission [42].
According to the data presented by Cherezov et al. [20],
Arg325 is a part of the α2 helical structure of the C-tern-
minal domain (Table 2). Arg has a helix-forming behavior
and its tendency is to stabilize α-helices [43]. Also, Trp
has a helix-forming behavior, which makes it unlikely that
the R325W mutation affects the α2-helix folding.
An obvious limitation of our study is largely inherent to
all theoretical models in biochemistry in general, which
never allow complete certainty [36]. Our model of the
ZnT-8 protein was based on a crystal structure of the E.
coli zinc transporter YiiP. In the future, a high resolution
ZnT-8 structure model will help to identify all specific
residues that may contribute to full transport activity of
zinc. Furthermore, we cannot fully exclude the possibility
that the presence of a Trp residue at position 325 does
not interfere with the binding of a putative zinc metal-
lochaperone. However, cross-sectional analyses of 75-g 3-
h oral glucose tolerance test results for a large sample of
Caucasians and for populations with an exceptionally
high prevalence of type 2 diabetes revealed inverted-U
plots of insulin vs. glucose in plasma, implying direct
proof of excellent insulin secretion during the pre-dia-
betic state, and consequently of adequate zinc transfer to
the correct sites in the pancreatic islet cells [44-46].
Conclusions
This modeling predicts that both Arg325 and Trp325,
amino acids with a helix-forming behavior and penulti-
mate N-terminal residues in the α2-helix of the C-termi-
nal domain, are shielded by the planar surface of the three
cytoplasmic β-strands and hence unable to affect the
sensing capacity of the C-terminal domain. Moreover, the
amino acid residue at position 325 is too far removed
from the docking and transporter parts to affect their
local protein conformations. These data suggest that the
inherited R325W abnormality in SLC30A8 may be toler-
ated and results in adequate zinc transfer to the correct
sites in the pancreatic islet cells and provide support to
assume that the SLC30A8 gene variant R325W has a low
predicted value for future type 2 diabetes at population-
based level [7-9].
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